The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients
About this study
The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 patients. The main questions it aims to answer are: \- Is giving 1 drops/ 10kg/ times, twice daily for 8 weeks will change the level of LDL and HDL level in diabetic type 2 patients compared to placebo? Researchers will compare propolis to a placebo (a look-alike substance that contains no drug) to see if propolis works to change LDL and HDL cholesterol level. Participants will: * Take propolis or a placebo, 2 times daily with given dose (1 drops/10 kg/times) every day for 2 months * Visit the sub-district health centre once every 2 weeks for checkups * Get their blood checked before and after intervention
- Condition
- Diabetes Mellitus Type 2
- Tested
- Propolis drops, Placebo
- Sponsor
- Universitas Indonesia
Who can join
- Age
- 35 to 59 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 35 years
- Maximum age: 59 years
- Study condition: Diabetes Mellitus Type 2
- Controlled Diabetes Mellitus type 2 with HbA1c \<7.5%
- BMI 23-35 kg/m2
- On anti-cholesterol therapy
Exclusion 7
- Using injection therapy (insulin or GLP-1 RA)
- History of bees product allergy
- Active smoker
- Consuming alcohol
- Altered liver (ALT\>35 IU/L) and kidney (eGFR\<90 mL/min) function
- Pregnant and breastfeeding women
- History of cardiovascular disease (heart attack, stroke)
Where
1 site, 1 recruiting
University of Indonesia Faculty of Biomedical Science
Jakarta, Indonesia
Contact
-
Dwirini R Gunarti, Biomed Science
+62 8118382301 rinairet@gmail.com
-
Wiryani Sentosa, MD
+62 81210977847 wiryani@ymail.com
Potential match only. Final eligibility is determined by the study team.